Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | 0.00% | -14.29% |
29/04 | Alterity Therapeutics Limited Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Diseases | CI |
16/04 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 20.44M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- ATH Stock
- News Alterity Therapeutics Limited
- Alterity Gets Authorization From New Zealand Medical Regulator for Phase 2 Trial of Product for Rare Parkinsonian Disorder